Editas Medicine, Inc. (NASDAQ:EDIT) Receives Average Analyst Rating of “Hold”By Publishing TeamJanuary 2, 2023 Shares of Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) received an average rating of “Hold” by the fourteen brokerages that…